U.S. market Closed. Opens in 1 day 10 hours 49 minutes

TNXP | Tonix Pharmaceuticals Holding Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Revenue7.77MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue4.74M112.09M92.31M50.51M28.83M26.32M21.29M38.97M48.16M27.66M10.89M6.66M3.38MN/A17.00K7.11K
Gross Profit3.03M-112.09M-92.31M-50.51M-28.83M-26.32M-21.29M-38.97M-48.16M-27.66M-10.89M-6.66M-3.38MN/A-17.00K-7.11K
Operating Expenses121.41M112.09M92.31M50.51M28.83M26.32M21.29M38.97M48.16M27.66M10.89M6.66M3.38M17.72K13.87K14.02K
Selling, General & Admin34.75M30.21M23.47M14.35M10.64M8.76M7.95M10.44M12.66M9.04M6.24M4.08M2.22M13.72K13.87K14.02K
Research & Development86.66M81.88M68.84M36.16M18.19M17.56M13.34M28.53M35.50M18.62M4.65M2.58M1.16MN/AN/AN/A
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A1.88KN/A4.00KN/AN/A
Operating Income-118.38M-112.09M-92.31M-50.51M-28.83M-26.32M-21.29M-38.97M-48.16M-27.66M-10.89M-6.66M-3.38M-17.72K-30.87K-21.13K
Other Expenses / Income1.72M1.87M25.00K48.00K210.00K233.00K168.00K127.00K108.00K40.00K4.00K-2.79M-91.58K-1.94MN/AN/A
Before Tax Income-116.66M-110.22M-92.29M-50.46M-28.62M-26.09M-21.12M-38.84M-48.05M-27.62M-10.88M-9.45M-3.47MN/AN/AN/A
Income Tax ExpensesN/A4.79M-75.00K-75.00K-236.00K233.00K-70.00K-206.00K-161.00K-36.00K-17.00K1.61M3.38M17.72K30.87K21.13K
Net Income-116.66M-116.88M-92.29M-52.17M-31.09M-29.36M-21.12M-38.84M-48.05M-27.62M-10.88M-9.45K-3.47M-17.72K-30.87K-21.13K
Interest ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A4.00K1.61MN/AN/AN/AN/A
Basic Shares Outstanding532.48K182.54K56.94K14.78KN/AN/AN/AN/AN/AN/AN/AN/A6.001.001.001.00
Diluted Shares Outstanding532.48K182.54K56.94K14.78KN/AN/AN/AN/AN/AN/AN/AN/A6.001.001.001.00
EBITDA-114.09M-110.84M-92.26M-50.48M-28.80M-26.27M-21.06M-38.76M-48.00M-27.62M-10.87M-6.65M-3.37M-17.72K-30.87K-21.13K
EBITDA Margin-1,468.70%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-116.66M-112.09M-92.36M-52.25M-31.33M-29.12M-21.19M-39.05M-48.22M-27.65M-10.90M3.22M-91.58KN/AN/AN/A
EBIT Margin-1,501.78%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙